Brand Name
Mycamine
Generic Name
Micafungin
View Brand Information FDA approval date: March 16, 2005
Classification: Echinocandin Antifungal
Form: Injection
What is Mycamine (Micafungin)?
MYCAMINE ® is indicated for: Treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses in adult and pediatric patients 4 months of age and older [see Clinical Studies ( 1.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment